MBX Biosciences (MBX) Minority Interest (2023 - 2024)
MBX Biosciences' (MBX) quarterly Minority Interest came in at $36.5 million in Q2 2024, little changed quarter-over-quarter from $36.5 million in Q1 2024.
MBX Biosciences (MBX) Minority Interest (2023 - 2024) Analysis & Trends
MBX Biosciences has disclosed Minority Interest across 2 years of filings, most recently posting $36.5 million for Q2 2024.
- Minority Interest for Q2 2024 came in at $36.5 million, changed N/A year-over-year; the trailing twelve-month figure through Jun 2024 was $36.5 million (changed N/A YoY), and the FY2023 annual result was $115.9 million, changed N/A from the prior year.
- Minority Interest came in at $36.5 million for Q2 2024 at MBX Biosciences, roughly flat from $36.5 million in the prior quarter.
- In the past five years, Minority Interest ranged from a high of $115.9 million in Q3 2023 to a low of $36.5 million in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - |
| 10 | MBX Biosciences | 1.44 Bn | 1.44 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 36.50 Mn |
| Mar 31, 2024 | 36.50 Mn |
| Dec 31, 2023 | 115.86 Mn |
| Sep 30, 2023 | 115.86 Mn |